logo
Plus   Neg
Share
Email

PDL BioPharma Inc. Bottom Line Drops In Q4

PDL BioPharma Inc. (PDLI) announced a profit for fourth quarter that dropped from the same period last year.

The company's profit came in at $16.28 million, or $0.11 per share. This compares with $22.34 million, or $0.15 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.08 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 33.7% to $45.12 million from $68.04 million last year.

PDL BioPharma Inc. earnings at a glance:

-Earnings (Q4): $16.28 Mln. vs. $22.34 Mln. last year.
-EPS (Q4): $0.11 vs. $0.15 last year.
-Analysts Estimate: $0.08
-Revenue (Q4): $45.12 Mln vs. $68.04 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT